Martin Brenner
Chief Executive & Scientific Officer iBio
Seminars
Thursday 29th October 2026
Unlocking Superior Obesity Outcomes by Preserving Muscle While Maximizing Fat Loss
9:00 am
- Exploring GLP-1 and muscle-expressing factor combinations that build muscle alongside fat loss to address GLP-1 induced sarcopenia
- Reviewing promising combination therapy and development innovations to maintain or improve lean mass during obesity treatments
- Determine the right development focus by evaluating whether muscle mass, muscle function, or overall muscle efficacy will be the most meaningful differentiator for future obesity therapies and clinical outcomes
